Mouse mammary tumors display Stat3 activation dependent on leukemia inhibitory factor signaling
- Autores
- Quaglino, A.; Schere-Levy, C.; Romorini, L.; Meiss, R.P.; Kordon, E.C.
- Año de publicación
- 2007
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Introduction: It has been demonstrated that leukemia inhibitory factor (LIF) induces epithelium apoptosis through Stat3 activation during mouse mammary gland involution. In contrast, it has been shown that this transcription factor is commonly activated in breast cancer cells, although what causes this effect remains unknown. Here we have tested the hypothesis that locally produced LIF can be responsible for Stat3 activation in mouse mammary tumors. Methods: The studies were performed in different tumorigenic and non-tumorigenic mammary cells. The expression of LIF and LIF receptor was tested by RT-PCR analysis. In tumors, LIF and Stat3 proteins were analyzed by immunohistochemistry, whereas Stat3 and extracellular signal-regulated kinase (ERK)1/2 expression and phosphorylation were studied by Western blot analysis. A LIF-specific blocking antibody was used to determine whether this cytokine was responsible for Stat3 phosphorylation induced by conditioned medium. Specific pharmacological inhibitors (PD98059 and Stat3ip) that affect ERK1/2 and Stat3 activation were used to study their involvement in LIF-induced effects. To analyze cell survival, assays with crystal violet were performed. Results: High levels of LIF expression and activated Stat3 were found in mammary tumors growing in vivo and in their primary cultures. We found a single mouse mammary tumor cell line, LM3, that showed low levels of activated Stat3. Incidentally, these cells also showed very little expression of LIF receptor. This suggested that autocrine/paracrine LIF would be responsible for Stat3 activation in mouse mammary tumors. This hypothesis was confirmed by the ability of conditioned medium of mammary tumor primary cultures to induce Stat3 phosphorylation, activity that was prevented by pretreatment with LIF-blocking antibody. Besides, we found that LIF increased tumor cell viability. Interestingly, blocking Stat3 activation enhanced this effect in mammary tumor cells. Conclusion: LIF is overexpressed in mouse mammary tumors, where it acts as the main Stat3 activator. Interestingly, the positive LIF effect on tumor cell viability is not dependent on Stat3 activation, which inhibits tumor cell survival as it does in normal mammary epithelium. © 2007 Quaglino et al.; licensee BioMed Central Ltd.
Fil:Quaglino, A. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina.
Fil:Schere-Levy, C. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina.
Fil:Romorini, L. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina.
Fil:Kordon, E.C. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. - Fuente
- Breast Cancer Res. 2007;9(5)
- Materia
-
2 (2 amino 3 methoxyphenyl)chromone
crystal violet
leukemia inhibitory factor
mitogen activated protein kinase 1
mitogen activated protein kinase 3
protein antibody
STAT3 protein
leukemia inhibitory factor
leukemia inhibitory factor receptor alpha
Lif protein, mouse
Lifr protein, mouse
messenger RNA
mitogen activated protein kinase 1
mitogen activated protein kinase 3
STAT3 protein
Stat3 protein, mouse
tyrosine
unclassified drug
animal cell
animal experiment
animal model
article
breast tumor
cell survival
female
human
human cell
immunohistochemistry
mouse
nonhuman
phosphorylation
protein analysis
protein expression
protein function
reverse transcription polymerase chain reaction
Western blotting
animal
Bagg albino mouse
cell culture
experimental neoplasm
fluorescent antibody technique
genetics
immunoprecipitation
metabolism
pathology
signal transduction
Animals
Blotting, Western
Cell Survival
Female
Fluorescent Antibody Technique
Immunoprecipitation
Leukemia Inhibitory Factor
Leukemia Inhibitory Factor Receptor alpha Subunit
Mammary Neoplasms, Experimental
Mice
Mice, Inbred BALB C
Mitogen-Activated Protein Kinase 1
Mitogen-Activated Protein Kinase 3
Phosphorylation
Reverse Transcriptase Polymerase Chain Reaction
RNA, Messenger
Signal Transduction
STAT3 Transcription Factor
Tumor Cells, Cultured
Tyrosine - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- http://creativecommons.org/licenses/by/2.5/ar
- Repositorio
- Institución
- Universidad Nacional de Buenos Aires. Facultad de Ciencias Exactas y Naturales
- OAI Identificador
- paperaa:paper_14655411_v9_n5_p_Quaglino
Ver los metadatos del registro completo
id |
BDUBAFCEN_daccbbc9c30236660300caf30ef55d56 |
---|---|
oai_identifier_str |
paperaa:paper_14655411_v9_n5_p_Quaglino |
network_acronym_str |
BDUBAFCEN |
repository_id_str |
1896 |
network_name_str |
Biblioteca Digital (UBA-FCEN) |
spelling |
Mouse mammary tumors display Stat3 activation dependent on leukemia inhibitory factor signalingQuaglino, A.Schere-Levy, C.Romorini, L.Meiss, R.P.Kordon, E.C.2 (2 amino 3 methoxyphenyl)chromonecrystal violetleukemia inhibitory factormitogen activated protein kinase 1mitogen activated protein kinase 3protein antibodySTAT3 proteinleukemia inhibitory factorleukemia inhibitory factor receptor alphaLif protein, mouseLifr protein, mousemessenger RNAmitogen activated protein kinase 1mitogen activated protein kinase 3STAT3 proteinStat3 protein, mousetyrosineunclassified druganimal cellanimal experimentanimal modelarticlebreast tumorcell survivalfemalehumanhuman cellimmunohistochemistrymousenonhumanphosphorylationprotein analysisprotein expressionprotein functionreverse transcription polymerase chain reactionWestern blottinganimalBagg albino mousecell cultureexperimental neoplasmfluorescent antibody techniquegeneticsimmunoprecipitationmetabolismpathologysignal transductionAnimalsBlotting, WesternCell SurvivalFemaleFluorescent Antibody TechniqueImmunoprecipitationLeukemia Inhibitory FactorLeukemia Inhibitory Factor Receptor alpha SubunitMammary Neoplasms, ExperimentalMiceMice, Inbred BALB CMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3PhosphorylationReverse Transcriptase Polymerase Chain ReactionRNA, MessengerSignal TransductionSTAT3 Transcription FactorTumor Cells, CulturedTyrosineIntroduction: It has been demonstrated that leukemia inhibitory factor (LIF) induces epithelium apoptosis through Stat3 activation during mouse mammary gland involution. In contrast, it has been shown that this transcription factor is commonly activated in breast cancer cells, although what causes this effect remains unknown. Here we have tested the hypothesis that locally produced LIF can be responsible for Stat3 activation in mouse mammary tumors. Methods: The studies were performed in different tumorigenic and non-tumorigenic mammary cells. The expression of LIF and LIF receptor was tested by RT-PCR analysis. In tumors, LIF and Stat3 proteins were analyzed by immunohistochemistry, whereas Stat3 and extracellular signal-regulated kinase (ERK)1/2 expression and phosphorylation were studied by Western blot analysis. A LIF-specific blocking antibody was used to determine whether this cytokine was responsible for Stat3 phosphorylation induced by conditioned medium. Specific pharmacological inhibitors (PD98059 and Stat3ip) that affect ERK1/2 and Stat3 activation were used to study their involvement in LIF-induced effects. To analyze cell survival, assays with crystal violet were performed. Results: High levels of LIF expression and activated Stat3 were found in mammary tumors growing in vivo and in their primary cultures. We found a single mouse mammary tumor cell line, LM3, that showed low levels of activated Stat3. Incidentally, these cells also showed very little expression of LIF receptor. This suggested that autocrine/paracrine LIF would be responsible for Stat3 activation in mouse mammary tumors. This hypothesis was confirmed by the ability of conditioned medium of mammary tumor primary cultures to induce Stat3 phosphorylation, activity that was prevented by pretreatment with LIF-blocking antibody. Besides, we found that LIF increased tumor cell viability. Interestingly, blocking Stat3 activation enhanced this effect in mammary tumor cells. Conclusion: LIF is overexpressed in mouse mammary tumors, where it acts as the main Stat3 activator. Interestingly, the positive LIF effect on tumor cell viability is not dependent on Stat3 activation, which inhibits tumor cell survival as it does in normal mammary epithelium. © 2007 Quaglino et al.; licensee BioMed Central Ltd.Fil:Quaglino, A. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina.Fil:Schere-Levy, C. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina.Fil:Romorini, L. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina.Fil:Kordon, E.C. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina.2007info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfhttp://hdl.handle.net/20.500.12110/paper_14655411_v9_n5_p_QuaglinoBreast Cancer Res. 2007;9(5)reponame:Biblioteca Digital (UBA-FCEN)instname:Universidad Nacional de Buenos Aires. Facultad de Ciencias Exactas y Naturalesinstacron:UBA-FCENenginfo:eu-repo/semantics/openAccesshttp://creativecommons.org/licenses/by/2.5/ar2025-10-23T11:18:28Zpaperaa:paper_14655411_v9_n5_p_QuaglinoInstitucionalhttps://digital.bl.fcen.uba.ar/Universidad públicaNo correspondehttps://digital.bl.fcen.uba.ar/cgi-bin/oaiserver.cgiana@bl.fcen.uba.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:18962025-10-23 11:18:30.011Biblioteca Digital (UBA-FCEN) - Universidad Nacional de Buenos Aires. Facultad de Ciencias Exactas y Naturalesfalse |
dc.title.none.fl_str_mv |
Mouse mammary tumors display Stat3 activation dependent on leukemia inhibitory factor signaling |
title |
Mouse mammary tumors display Stat3 activation dependent on leukemia inhibitory factor signaling |
spellingShingle |
Mouse mammary tumors display Stat3 activation dependent on leukemia inhibitory factor signaling Quaglino, A. 2 (2 amino 3 methoxyphenyl)chromone crystal violet leukemia inhibitory factor mitogen activated protein kinase 1 mitogen activated protein kinase 3 protein antibody STAT3 protein leukemia inhibitory factor leukemia inhibitory factor receptor alpha Lif protein, mouse Lifr protein, mouse messenger RNA mitogen activated protein kinase 1 mitogen activated protein kinase 3 STAT3 protein Stat3 protein, mouse tyrosine unclassified drug animal cell animal experiment animal model article breast tumor cell survival female human human cell immunohistochemistry mouse nonhuman phosphorylation protein analysis protein expression protein function reverse transcription polymerase chain reaction Western blotting animal Bagg albino mouse cell culture experimental neoplasm fluorescent antibody technique genetics immunoprecipitation metabolism pathology signal transduction Animals Blotting, Western Cell Survival Female Fluorescent Antibody Technique Immunoprecipitation Leukemia Inhibitory Factor Leukemia Inhibitory Factor Receptor alpha Subunit Mammary Neoplasms, Experimental Mice Mice, Inbred BALB C Mitogen-Activated Protein Kinase 1 Mitogen-Activated Protein Kinase 3 Phosphorylation Reverse Transcriptase Polymerase Chain Reaction RNA, Messenger Signal Transduction STAT3 Transcription Factor Tumor Cells, Cultured Tyrosine |
title_short |
Mouse mammary tumors display Stat3 activation dependent on leukemia inhibitory factor signaling |
title_full |
Mouse mammary tumors display Stat3 activation dependent on leukemia inhibitory factor signaling |
title_fullStr |
Mouse mammary tumors display Stat3 activation dependent on leukemia inhibitory factor signaling |
title_full_unstemmed |
Mouse mammary tumors display Stat3 activation dependent on leukemia inhibitory factor signaling |
title_sort |
Mouse mammary tumors display Stat3 activation dependent on leukemia inhibitory factor signaling |
dc.creator.none.fl_str_mv |
Quaglino, A. Schere-Levy, C. Romorini, L. Meiss, R.P. Kordon, E.C. |
author |
Quaglino, A. |
author_facet |
Quaglino, A. Schere-Levy, C. Romorini, L. Meiss, R.P. Kordon, E.C. |
author_role |
author |
author2 |
Schere-Levy, C. Romorini, L. Meiss, R.P. Kordon, E.C. |
author2_role |
author author author author |
dc.subject.none.fl_str_mv |
2 (2 amino 3 methoxyphenyl)chromone crystal violet leukemia inhibitory factor mitogen activated protein kinase 1 mitogen activated protein kinase 3 protein antibody STAT3 protein leukemia inhibitory factor leukemia inhibitory factor receptor alpha Lif protein, mouse Lifr protein, mouse messenger RNA mitogen activated protein kinase 1 mitogen activated protein kinase 3 STAT3 protein Stat3 protein, mouse tyrosine unclassified drug animal cell animal experiment animal model article breast tumor cell survival female human human cell immunohistochemistry mouse nonhuman phosphorylation protein analysis protein expression protein function reverse transcription polymerase chain reaction Western blotting animal Bagg albino mouse cell culture experimental neoplasm fluorescent antibody technique genetics immunoprecipitation metabolism pathology signal transduction Animals Blotting, Western Cell Survival Female Fluorescent Antibody Technique Immunoprecipitation Leukemia Inhibitory Factor Leukemia Inhibitory Factor Receptor alpha Subunit Mammary Neoplasms, Experimental Mice Mice, Inbred BALB C Mitogen-Activated Protein Kinase 1 Mitogen-Activated Protein Kinase 3 Phosphorylation Reverse Transcriptase Polymerase Chain Reaction RNA, Messenger Signal Transduction STAT3 Transcription Factor Tumor Cells, Cultured Tyrosine |
topic |
2 (2 amino 3 methoxyphenyl)chromone crystal violet leukemia inhibitory factor mitogen activated protein kinase 1 mitogen activated protein kinase 3 protein antibody STAT3 protein leukemia inhibitory factor leukemia inhibitory factor receptor alpha Lif protein, mouse Lifr protein, mouse messenger RNA mitogen activated protein kinase 1 mitogen activated protein kinase 3 STAT3 protein Stat3 protein, mouse tyrosine unclassified drug animal cell animal experiment animal model article breast tumor cell survival female human human cell immunohistochemistry mouse nonhuman phosphorylation protein analysis protein expression protein function reverse transcription polymerase chain reaction Western blotting animal Bagg albino mouse cell culture experimental neoplasm fluorescent antibody technique genetics immunoprecipitation metabolism pathology signal transduction Animals Blotting, Western Cell Survival Female Fluorescent Antibody Technique Immunoprecipitation Leukemia Inhibitory Factor Leukemia Inhibitory Factor Receptor alpha Subunit Mammary Neoplasms, Experimental Mice Mice, Inbred BALB C Mitogen-Activated Protein Kinase 1 Mitogen-Activated Protein Kinase 3 Phosphorylation Reverse Transcriptase Polymerase Chain Reaction RNA, Messenger Signal Transduction STAT3 Transcription Factor Tumor Cells, Cultured Tyrosine |
dc.description.none.fl_txt_mv |
Introduction: It has been demonstrated that leukemia inhibitory factor (LIF) induces epithelium apoptosis through Stat3 activation during mouse mammary gland involution. In contrast, it has been shown that this transcription factor is commonly activated in breast cancer cells, although what causes this effect remains unknown. Here we have tested the hypothesis that locally produced LIF can be responsible for Stat3 activation in mouse mammary tumors. Methods: The studies were performed in different tumorigenic and non-tumorigenic mammary cells. The expression of LIF and LIF receptor was tested by RT-PCR analysis. In tumors, LIF and Stat3 proteins were analyzed by immunohistochemistry, whereas Stat3 and extracellular signal-regulated kinase (ERK)1/2 expression and phosphorylation were studied by Western blot analysis. A LIF-specific blocking antibody was used to determine whether this cytokine was responsible for Stat3 phosphorylation induced by conditioned medium. Specific pharmacological inhibitors (PD98059 and Stat3ip) that affect ERK1/2 and Stat3 activation were used to study their involvement in LIF-induced effects. To analyze cell survival, assays with crystal violet were performed. Results: High levels of LIF expression and activated Stat3 were found in mammary tumors growing in vivo and in their primary cultures. We found a single mouse mammary tumor cell line, LM3, that showed low levels of activated Stat3. Incidentally, these cells also showed very little expression of LIF receptor. This suggested that autocrine/paracrine LIF would be responsible for Stat3 activation in mouse mammary tumors. This hypothesis was confirmed by the ability of conditioned medium of mammary tumor primary cultures to induce Stat3 phosphorylation, activity that was prevented by pretreatment with LIF-blocking antibody. Besides, we found that LIF increased tumor cell viability. Interestingly, blocking Stat3 activation enhanced this effect in mammary tumor cells. Conclusion: LIF is overexpressed in mouse mammary tumors, where it acts as the main Stat3 activator. Interestingly, the positive LIF effect on tumor cell viability is not dependent on Stat3 activation, which inhibits tumor cell survival as it does in normal mammary epithelium. © 2007 Quaglino et al.; licensee BioMed Central Ltd. Fil:Quaglino, A. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. Fil:Schere-Levy, C. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. Fil:Romorini, L. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. Fil:Kordon, E.C. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. |
description |
Introduction: It has been demonstrated that leukemia inhibitory factor (LIF) induces epithelium apoptosis through Stat3 activation during mouse mammary gland involution. In contrast, it has been shown that this transcription factor is commonly activated in breast cancer cells, although what causes this effect remains unknown. Here we have tested the hypothesis that locally produced LIF can be responsible for Stat3 activation in mouse mammary tumors. Methods: The studies were performed in different tumorigenic and non-tumorigenic mammary cells. The expression of LIF and LIF receptor was tested by RT-PCR analysis. In tumors, LIF and Stat3 proteins were analyzed by immunohistochemistry, whereas Stat3 and extracellular signal-regulated kinase (ERK)1/2 expression and phosphorylation were studied by Western blot analysis. A LIF-specific blocking antibody was used to determine whether this cytokine was responsible for Stat3 phosphorylation induced by conditioned medium. Specific pharmacological inhibitors (PD98059 and Stat3ip) that affect ERK1/2 and Stat3 activation were used to study their involvement in LIF-induced effects. To analyze cell survival, assays with crystal violet were performed. Results: High levels of LIF expression and activated Stat3 were found in mammary tumors growing in vivo and in their primary cultures. We found a single mouse mammary tumor cell line, LM3, that showed low levels of activated Stat3. Incidentally, these cells also showed very little expression of LIF receptor. This suggested that autocrine/paracrine LIF would be responsible for Stat3 activation in mouse mammary tumors. This hypothesis was confirmed by the ability of conditioned medium of mammary tumor primary cultures to induce Stat3 phosphorylation, activity that was prevented by pretreatment with LIF-blocking antibody. Besides, we found that LIF increased tumor cell viability. Interestingly, blocking Stat3 activation enhanced this effect in mammary tumor cells. Conclusion: LIF is overexpressed in mouse mammary tumors, where it acts as the main Stat3 activator. Interestingly, the positive LIF effect on tumor cell viability is not dependent on Stat3 activation, which inhibits tumor cell survival as it does in normal mammary epithelium. © 2007 Quaglino et al.; licensee BioMed Central Ltd. |
publishDate |
2007 |
dc.date.none.fl_str_mv |
2007 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/20.500.12110/paper_14655411_v9_n5_p_Quaglino |
url |
http://hdl.handle.net/20.500.12110/paper_14655411_v9_n5_p_Quaglino |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess http://creativecommons.org/licenses/by/2.5/ar |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
http://creativecommons.org/licenses/by/2.5/ar |
dc.format.none.fl_str_mv |
application/pdf |
dc.source.none.fl_str_mv |
Breast Cancer Res. 2007;9(5) reponame:Biblioteca Digital (UBA-FCEN) instname:Universidad Nacional de Buenos Aires. Facultad de Ciencias Exactas y Naturales instacron:UBA-FCEN |
reponame_str |
Biblioteca Digital (UBA-FCEN) |
collection |
Biblioteca Digital (UBA-FCEN) |
instname_str |
Universidad Nacional de Buenos Aires. Facultad de Ciencias Exactas y Naturales |
instacron_str |
UBA-FCEN |
institution |
UBA-FCEN |
repository.name.fl_str_mv |
Biblioteca Digital (UBA-FCEN) - Universidad Nacional de Buenos Aires. Facultad de Ciencias Exactas y Naturales |
repository.mail.fl_str_mv |
ana@bl.fcen.uba.ar |
_version_ |
1846784880930717696 |
score |
12.982451 |